Several possible studies
Story checked
Now measurable in plasma: eMTBR-Tau (opens in a new tab)
news-medical.net · 2026-09-29
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Now measurable in plasma: eMTBR-Tau
news-medical.net · 2026-09-29
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedTau tangles are closely linked to Alzheimer’s disease progression, but the tau species associated with these aggregates are present at exceptionally low levels in blood, making them difficult to measure.View evidenceHide evidence
As statedexceptionally low levels in blood
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 4Not checkedSpear Bio has introduced the first commercially available singleplex immunoassay for plasma eMTBR-Tau.View evidenceHide evidence
As statedfirst commercially available singleplex immunoassay
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 4Not checkedA webinar will explore the science and research potential of plasma eMTBR-Tau as an emerging biomarker, including how it may differ from established plasma pTau biomarkers.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 4Not checkedThe webinar will discuss results from amyloid- and tau-PET–characterized research cohorts and what they suggest about possible applications for the biomarker.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
Crossref · 15 candidate papers
QUANTITATION OF MICROTOBULE ASSOCIATED PROTEIN TAU IN PAIRED HELICAL FILAMENTS BY IMMUNOASSAY
Alzheimer Disease & Associated Disorders · 1988 · Crossref
Evolving Role of Plasma Phosphorylated Tau 217 in Alzheimer Disease—Time for Tau
JAMA Neurology · 2025 · Crossref
Alzheimer??s disease and tau proteins
Alzheimer Disease & Associated Disorders · 1987 · Crossref
Identifying Potential Alzheimer�s Disease Biomarkers Beyond Amyloid-Beta and Tau
Crossref
Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer??s disease
Alzheimer Disease & Associated Disorders · 1987 · Crossref
And 10 more candidates considered.